Screener
ArriVent BioPharma, Inc. AVBP Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by ArriVent BioPharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The source filing: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-058650
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $62,103 | $45,540 |
| Short-term investments | 264,277 | 267,281 |
| Prepaid expenses and other current assets | 22,320 | 20,076 |
| Total current assets | 348,700 | 332,897 |
| Right of use assets – operating leases | 370 | 13 |
| Deferred offering costs | 69 | 69 |
| Other assets | 156 | 190 |
Item 1. Condensed Financial Statements (Unaudited):
FAQ
- What is ArriVent BioPharma, Inc.'s prepaid & other current?
- ArriVent BioPharma, Inc. (AVBP) reported prepaid & other current of $22.32M in Q1 2026.
- How has ArriVent BioPharma, Inc.'s prepaid & other current changed year-over-year?
- ArriVent BioPharma, Inc.'s prepaid & other current increased by 129.9% year-over-year, from $9.71M to $22.32M.
- What is the long-term trend for ArriVent BioPharma, Inc.'s prepaid & other current?
- Over 2 years (2023 to 2025), ArriVent BioPharma, Inc.'s prepaid & other current has grown at a 306.3% compound annual growth rate (CAGR), from $3.95M to $65.2M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about ArriVent BioPharma, Inc.'s prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude